Skip to main content

NIV-142 20 mg Pill - yellow & white capsule/oblong, 18mm

Pill with imprint NIV-142 20 mg is Yellow & White, Capsule/Oblong and has been identified as Temozolomide 20 mg. It is supplied by Nivagen Pharmaceuticals, Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NIV-142 20 mg

Temozolomide

Imprint
NIV-142 20 mg
Strength
20 mg
Color
Yellow & White
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Nivagen Pharmaceuticals, Inc.
National Drug Code (NDC)
75834-0142
Inactive Ingredients
gelatin, titanium dioxide, ferric oxide yellow, shellac, butyl alcohol, isopropyl alcohol, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide, water, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.